ArticleOncology reports2019

Potential efficacy and prognosis of silencing the CRLF2‑mediated AKT/mTOR pathway in pediatric acute B‑cell lymphoblastic leukemia.

Min Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.